---

---

symbols : GSK   

save search

---

Pulmonary Drug Delivery Systems Global Market Forecasts to 2026: Focus on Metered-dose Inhalers, Dry Powered Inhalers, Soft Mist Inhalers and Nebulizers
Published: 2022-01-21 (Crawled : 12:30) - prnewswire.com
GLAXF | News | $22.8 | |

Health Technology

| 0.0% | O: -1.43% H: 0.0% C: -2.91%
AZN | News | $60.17 | |

Health Technology

| 0.0% | O: -0.58% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| 0.0% | O: -0.09% H: 0.0% C: 0.0%
AZNCF | News | $121.21 | |

Health Technology

| 0.0% | O: -0.32% H: 0.0% C: 0.0%
drug liver system drug delivery

---

Cancer Supportive Care Drugs Market to Reach $24.40 Bn, Globally, by 2030 at 2.2% CAGR: Allied Market Research
Published: 2022-01-20 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $22.8 | |

Health Technology

| 0.95% | O: 0.95% H: 0.0% C: 0.0%
AMGN | $233.73 | |

Health Technology

| -0.0% | O: -0.0% H: 0.0% C: -2.07%
JNJ | News | $167.27 | |

Health Technology

| 0.06% | O: 0.06% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| -1.78% | O: -1.78% H: 0.0% C: 0.0%
BAX | $85.74 | |

Health Technology

| -0.29% | O: -0.27% H: 2.1% C: 0.27%
drug research cancer

---

Global Professional Acne Medication Market (2022 to 2030) - Opportunity Analysis and Industry Forecast
Published: 2022-01-19 (Crawled : 19:00) - prnewswire.com
JNJ | News | $167.27 | |

Health Technology

| 0.06% | O: 0.06% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| -1.78% | O: -1.78% H: 0.0% C: 0.0%
VTRS | $14.64 | |

Health Technology

| -0.54% | O: -0.51% H: 1.6% C: -0.03%
BHC | News | $25.53 | |

Health Technology

| -4.51% | O: -4.51% H: 0.0% C: 0.0%
GLAXF | News | $22.8 | |

Health Technology

| 0.95% | O: 0.95% H: 0.0% C: 0.0%
acne

---

Brain Tumor Therapeutics Market to Record 9.10% Y-O-Y Growth Rate in 2021 | Amgen Inc. and Bristol-Myers Squibb Co. Among Key Vendors | Technavio
Published: 2022-01-19 (Crawled : 09:00) - prnewswire.com
NVS | News | $88.91 | |

Health Technology

| -0.6% | O: -0.6% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| -2.61% | O: -0.84% H: 0.0% C: 0.0%
NVSEF | News | $88.6 | |

Health Technology

| -0.14% | O: -0.14% H: 0.0% C: 0.0%
GLAXF | News | $22.8 | |

Health Technology

| -2.56% | O: -1.71% H: 0.22% C: -1.8%
AMGN | $233.73 | |

Health Technology

| -0.15% | O: -0.15% H: 0.0% C: 0.0%
era therapeutics growth

---

Tendinitis Treatment Market to grow at a CAGR of 6.79% by 2026 |Evolving Opportunities with Abbott Laboratories and Alvogen ehf | 17000+ Technavio Reports
Published: 2022-01-19 (Crawled : 07:00) - prnewswire.com
GLAXF | News | $22.8 | |

Health Technology

| -2.56% | O: -1.71% H: 0.22% C: -1.8%
AZN | News | $60.17 | |

Health Technology

| 1.4% | O: 0.44% H: 0.41% C: -0.2%
GSK | News | $45.14 | |

Health Technology

| -2.61% | O: -0.84% H: 0.0% C: 0.0%
AZNCF | News | $121.21 | |

Health Technology

| 1.86% | O: -0.26% H: 0.83% C: 0.83%
ABT | News | $126.36 | |

Health Technology

| -1.07% | O: -0.7% H: 0.0% C: 0.0%
treatment report

---

23andMe Announces Extension of GSK Collaboration and Update on Joint Immuno-oncology Program
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
GLAXF | News | $22.8 | |

Health Technology

| -0.44% | O: -3.8% H: 6.54% C: 6.21%
GSK | News | $45.14 | |

Health Technology

| -0.33% | O: 2.34% H: 0.0% C: 0.0%
ces collaboration

---

BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
JNJ | News | $167.27 | |

Health Technology

| -1.32% | O: -0.53% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| -0.68% | O: -0.35% H: 0.0% C: 0.0%
LLY | News | $246.46 | |

Health Technology

| -2.97% | O: -1.46% H: 0.0% C: 0.0%
AMRX | $4.4 | |

Health Technology

| -6.18% | O: -1.71% H: 0.0% C: 0.0%
MRTX | News | $118.34 | |

Health Technology

| -2.23% | O: -2.14% H: 0.0% C: 0.0%
GILD | $67.81 | |

Health Technology

| -6.0% | O: -0.32% H: 0.0% C: 0.0%
GLAXF | News | $22.8 | |

Health Technology

| 1.45% | O: -1.67% H: 3.62% C: 3.62%
PPG | $159.7 | |

Process Industries

| -5.74% | O: -2.07% H: 0.0% C: 0.0%
AMGN | $233.73 | |

Health Technology

| 0.71% | O: -0.53% H: 0.0% C: 0.0%
PHAT | $15.0 | |

Health Technology

| -1.77% | O: -3.08% H: 0.0% C: 0.0%
space spac

---

GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | News 3 d | $105.0 | |

Health Technology

| 0.08% | O: 0.0% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| -0.4% | O: 0.29% H: 0.0% C: 0.0%
VIR | $33.14 | |

Health Technology

| -17.17% | O: 1.05% H: 1.98% C: -6.88%
SNY | News 3 d | $52.31 | |

Health Technology

| 1.77% | O: -0.74% H: 0.0% C: 0.0%
XNCR | $34.83 | |

Health Technology

| -4.44% | O: 0.38% H: 1.12% C: -1.31%
covid-19 treatment fda application covid authorization merge

---

41% of Growth to Originate from North America for Microbial Products Market |Evolving Opportunities with bioMerieux SA, GlaxoSmithKline Plc & Kyowa Hakko Bio Co. Ltd. |17000+ Technavio Reports
Published: 2022-01-13 (Crawled : 05:00) - prnewswire.com
SNYNF | News 3 d | $105.0 | |

Health Technology

| 0.08% | O: 0.0% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| -0.4% | O: 0.29% H: 0.0% C: 0.0%
NVS | News | $88.91 | |

Health Technology

| -0.34% | O: 1.31% H: 0.0% C: 0.0%
TMO | $595.43 | |

Health Technology

| -4.03% | O: 0.69% H: 0.19% C: -3.81%
SNY | News 3 d | $52.31 | |

Health Technology

| 1.77% | O: -0.74% H: 0.0% C: 0.0%
america growth

---

Global End Stage Renal Disease Market 2021-2027: Low Maintenance Dialysis Equipment and Artificial Kidneys are Expected to Drive Market Growth
Published: 2022-01-11 (Crawled : 17:00) - prnewswire.com
MDT | News | $106.11 | |

Health Technology

| 0.46% | O: 0.48% H: 0.0% C: 0.0%
SNY | News 3 d | $52.31 | |

Health Technology

| 4.31% | O: 1.58% H: 0.0% C: 0.0%
GLAXF | News | $22.8 | |

Health Technology

| 3.64% | O: 0.55% H: 0.0% C: 0.0%
AMGN | $233.73 | |

Health Technology

| 2.14% | O: 0.71% H: 0.0% C: 0.0%
NVS | News | $88.91 | |

Health Technology

| -1.3% | O: -0.84% H: 0.0% C: 0.0%
SNYNF | News 3 d | $105.0 | |

Health Technology

| 2.7% | O: -3.41% H: 5.99% C: 1.1%
GSK | News | $45.14 | |

Health Technology

| 0.67% | O: -0.37% H: 0.0% C: 0.0%
BMY | $64.58 | |

Health Technology

| -0.8% | O: -0.41% H: 0.0% C: 0.0%

---

Global Depression Drugs Market to Surpass US$ 15,379.0 Million by 2028, Says Coherent Market Insights
Published: 2022-01-07 (Crawled : 19:00) - prnewswire.com
PFE | $54.05 | |

Health Technology

AZNCF | News | $121.21 | |

Health Technology

SNYNF | News 3 d | $105.0 | |

Health Technology

TAK | $14.4 | |

Health Technology

SNY | News 3 d | $52.31 | |

Health Technology

LLY | News | $246.46 | |

Health Technology

GLAXF | News | $22.8 | |

Health Technology

GSK | News | $45.14 | |

Health Technology

AZN | News | $60.17 | |

Health Technology

JNJ | News | $167.27 | |

Health Technology

drug depression

---

908 Devices Announces GSK Purchases Fifth REBEL Cell Culture Media Analyzer
Published: 2022-01-07 (Crawled : 13:00) - biospace.com/
GSK | News | $45.14 | |

Health Technology

| 3.67% | O: 0.05% H: 0.0% C: 0.0%
MASS | $15.13 | |

| -34.62% | O: -10.29% H: 0.0% C: 0.0%
ces device cel media

---

Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
Published: 2022-01-06 (Crawled : 14:00) - biospace.com/
FATE | $38.3 | |

Health Technology

| -26.15% | O: -0.56% H: 2.27% C: -4.25%
AKRO | $20.01 | |

Health Technology

| 0.7% | O: -0.35% H: 4.23% C: 3.03%
GLAXF | News | $22.8 | |

Health Technology

| 6.79% | O: -2.58% H: 1.2% C: 0.05%
LEGN | $39.19 | |

Health Technology

| -15.76% | O: -7.55% H: 3.65% C: 3.07%
AMGN | $233.73 | |

Health Technology

| 3.15% | O: -0.64% H: 0.67% C: 0.01%
GILD | $67.81 | |

Health Technology

| -6.3% | O: -0.96% H: 0.58% C: -0.12%
XLO | $13.93 | |

Professional, Scientific, and T...

| -6.82% | O: 0.33% H: 5.33% C: -4.47%
GSK | News | $45.14 | |

Health Technology

| 2.68% | O: -0.96% H: 0.0% C: 0.0%
era therapeutics

---

Global Hepatorenal Syndrome Treatment Market Research Report (2021 to 2026) - by Type, Treatment, End-user and Region
Published: 2022-01-04 (Crawled : 21:00) - prnewswire.com
GLAXF | News | $22.8 | |

Health Technology

| 7.7% | O: 0.57% H: 1.57% C: 0.28%
MDT | News | $106.11 | |

Health Technology

| 0.08% | O: 1.01% H: 0.0% C: 0.0%
BDX | $263.97 | |

Health Technology

| 4.31% | O: -0.76% H: 0.0% C: 0.0%
SNY | News 3 d | $52.31 | |

Health Technology

| 5.36% | O: 0.91% H: 0.0% C: 0.0%
SNYNF | News 3 d | $105.0 | |

Health Technology

| 6.57% | O: 3.68% H: 0.0% C: 0.0%
JNJ | News | $167.27 | |

Health Technology

| -2.2% | O: 0.52% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| 3.67% | O: 0.96% H: 0.0% C: 0.0%
BAX | $85.74 | |

Health Technology

| -2.57% | O: 0.04% H: 0.0% C: 0.0%
CPIX | $3.66 | |

Health Technology

| -33.94% | O: -13.36% H: 0.0% C: 0.0%
EW | $115.56 | |

Health Technology

| -9.64% | O: -0.12% H: 0.0% C: 0.0%
LJPC | $4.55 | |

Health Technology

| -4.61% | O: 0.21% H: 4.19% C: -6.06%
BIVI | $4.56 | |

Health Technology

| -6.94% | O: 2.86% H: 12.1% C: 12.1%
treatment renal research

---

Global Drug Delivery Devices Market Research Report (2021 to 2026) - by Route of Administration, Vehicles, Application, End-user and Region
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $22.8 | |

Health Technology

| 3.64% | O: -3.82% H: 1.65% C: 0.04%
BDX | $263.97 | |

Health Technology

| 5.42% | O: 1.06% H: 0.0% C: 0.0%
MMM | $178.23 | |

Producer Manufacturing

| -0.04% | O: 0.1% H: 0.0% C: 0.0%
SNY | News 3 d | $52.31 | |

Health Technology

| 3.22% | O: -2.03% H: 0.0% C: 0.0%
OSUR | $8.67 | |

Health Technology

| 0.12% | O: 0.23% H: 0.0% C: 0.0%
ATRS | $3.35 | |

Health Technology

| -6.16% | O: 0.56% H: 0.0% C: -2.51%
PANA | $9.731 | |

Finance

| 0.32% | O: 0.72% H: 0.0% C: -0.72%
JNJ | News | $167.27 | |

Health Technology

| -1.7% | O: 0.51% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| 3.37% | O: -0.23% H: 0.62% C: -0.07%
BAX | $85.74 | |

Health Technology

| -1.3% | O: 0.13% H: 1.18% C: 1.17%
WST | $373.59 | |

Health Technology

| -16.22% | O: -0.79% H: 0.66% C: -3.03%
PHG | News | $33.79 | |

Health Technology

| -10.91% | O: -0.32% H: 0.0% C: 0.0%
ABT | News | $126.36 | |

Health Technology

| -9.52% | O: -0.06% H: 0.0% C: 0.0%
PODD | $232.32 | |

Health Technology

| -13.61% | O: 2.92% H: 2.2% C: -1.17%
application ces drug device research liver vehicles drug delivery

---

Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors
Published: 2021-12-27 (Crawled : 22:00) - biospace.com/
GSK | News | $45.14 | |

Health Technology

| 3.15% | O: 0.39% H: 0.43% C: 0.36%
BVXV | $1.58 | |

Health Technology

| -43.17% | O: -17.63% H: 2.62% C: 1.75%
GLAXF | News | $22.8 | |

Health Technology

| 9.35% | O: 5.52% H: 0.0% C: -4.05%
vaccine

---

Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19
Published: 2021-12-17 (Crawled : 13:30) - globenewswire.com
SNYNF | News 3 d | $105.0 | |

Health Technology

| 9.0% | O: -0.48% H: 0.0% C: 0.0%
GSK | News | $45.14 | |

Health Technology

| 4.42% | O: 0.86% H: 0.0% C: 0.0%
VIR | $33.14 | |

Health Technology

| -40.3% | O: -4.59% H: 0.0% C: 0.0%
SNY | News 3 d | $52.31 | |

Health Technology

| 6.21% | O: 0.22% H: 0.0% C: 0.0%
GLAXF | News | $22.8 | |

Health Technology

| 7.55% | O: 2.36% H: 0.46% C: 0.46%
XNCR | $34.83 | |

Health Technology

| -4.8% | O: -0.45% H: 0.0% C: 0.0%
covid-19 treatment europe granted covid authorization

---

Outlook on the Antifungal Drugs Global Market to 2026 - by Drug Class, Indication and Region
Published: 2021-12-16 (Crawled : 15:30) - prnewswire.com
NVSEF | News | $88.6 | |

Health Technology

| 10.93% | O: 6.92% H: 0.0% C: 0.0%
ALPMY | News | $16.71 | |

Manufacturing

| 5.03% | O: 1.7% H: 0.06% C: -0.49%
SNY | News 3 d | $52.31 | |

Health Technology

| 8.25% | O: 1.91% H: 0.0% C: 0.0%
GLAXF | News | $22.8 | |

Health Technology

| 9.56% | O: 0.67% H: 4.06% C: 1.19%
NVS | News | $88.91 | |

Health Technology

| 10.13% | O: 5.97% H: 0.0% C: 0.0%
ABT | News | $126.36 | |

Health Technology

| -5.23% | O: 1.49% H: 0.0% C: 0.0%
SNYNF | News 3 d | $105.0 | |

Health Technology

| 4.53% | O: -5.02% H: 5.6% C: 0.96%
GSK | News | $45.14 | |

Health Technology

| 3.39% | O: -0.98% H: 0.0% C: 0.0%
drug

---

Thyroid Gland Disorder Treatment Market Records a CAGR of 4.63% by 2025|35% of Growth to Originate from North America |17000+ Technavio Reports
Published: 2021-12-14 (Crawled : 12:30) - prnewswire.com
GLAXF | News | $22.8 | |

Health Technology

| 7.16% | O: -3.37% H: 0.0% C: 0.0%
AMGN | $233.73 | |

Health Technology

| 10.85% | O: 0.22% H: 1.65% C: 1.15%
VTRS | $14.64 | |

Health Technology

| 16.19% | O: -0.4% H: 4.78% C: 2.07%
GSK | News | $45.14 | |

Health Technology

| 4.66% | O: -0.77% H: 0.6% C: 0.23%
ABBV | News | $134.37 | |

Health Technology

| 7.32% | O: 0.49% H: 0.0% C: 0.0%
ABT | News | $126.36 | |

Health Technology

| -6.07% | O: 0.75% H: 0.0% C: 0.0%
treatment order growth

---

Mouthwash Market in India to Grow at a CAGR of 15.68% | Outlook to 2026; Market Size, Growth and Forecast Analytics | Technavio
Published: 2021-12-11 (Crawled : 04:20) - prnewswire.com
GSK | News | $45.14 | |

Health Technology

RYLPF | $34.24 | |

Health Technology

RBGPF | $86.23 | |

Consumer Non-Durables

GLAXF | News | $22.8 | |

Health Technology

RBGLY | $17.68 | |

Manufacturing

analytics india growth

---

Your saved searches

---

Mentioned Today

COTY | News | $8.64 | |

Consumer Non-Durables

DXR | News | $11.16 | |

Health Technology

FCFS | News | $73.31 | |

Finance

INCY | News | $74.76 | |

Health Technology

KRP | News | $14.73 | |

Miscellaneous

LLY | News | $246.46 | |

Health Technology

OVLY | News | $17.6 | |

Finance